ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Decoy Therapeutics Inc
0.7548
-0.0050
-0.66%
成交量:
1.99万
成交额:
1.55万
市值:
481.88万
市盈率:
-0.02
高:
0.7800
开:
0.7800
低:
0.7514
收:
0.7598
52周最高:
34.65
52周最低:
0.5148
股本:
638.42万
流通股本:
634.11万
量比:
3.98
换手率:
0.31%
股息:
- -
股息率:
- -
每股收益(TTM):
-39.1909
每股收益(LYR):
-86.9214
净资产收益率:
-139.55%
总资产收益率:
-69.91%
市净率:
1.13
市盈率(LYR):
-0.01
数据加载中...
总览
公司
新闻资讯
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻资讯
Decoy Therapeutics参与虚拟投资者会议“这意味着什么”环节,重点介绍近期宣布的全球准入承诺协议
美股速递
·
02/04
BUZZ-盖茨基金会支持抗病毒药物的获取,诱饵治疗公司(Decoy Therapeutics)崛起
路透中文
·
01/13
Salarius Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.94%报0.567美元
市场透视
·
01/06
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/DCOY"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DCOY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DCOY\",,,,,undefined,":{"symbol":"DCOY","market":"US","secType":"STK","nameCN":"Decoy Therapeutics Inc","latestPrice":0.7548,"timestamp":1771512314414,"preClose":0.7598,"halted":0,"volume":19898,"delay":0,"changeRate":-0.006580679126085818,"floatShares":6341106,"shares":6384200,"eps":-39.1909,"marketStatus":"交易中","change":-0.005,"latestTime":"02-19 09:46:53 EST","open":0.78,"high":0.78,"low":0.7514,"amount":15482.3233912,"amplitude":0.037641,"askPrice":0.7994,"askSize":100,"bidPrice":0.7422,"bidSize":219,"shortable":3,"etf":0,"ttmEps":-39.1909,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771534800000},"marketStatusCode":2,"adr":0,"listingDate":1422507600000,"exchange":"NASDAQ","adjPreClose":0.7598,"preHourTrading":{"tag":"盘前","latestPrice":0.7444,"preClose":0.7598,"latestTime":"09:08 EST","volume":4926,"amount":3664.439085,"timestamp":1771510102091,"change":-0.0154,"changeRate":-0.020268,"amplitude":0.023164},"postHourTrading":{"tag":"盘后","latestPrice":0.726061,"preClose":0.7598,"latestTime":"19:01 EST","volume":3910,"amount":2818.28784,"timestamp":1771459297371,"change":-0.033739,"changeRate":-0.044405,"amplitude":0.052382},"volumeRatio":3.983944},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DCOY\",,,,,undefined,":{"symbol":"DCOY","floatShares":6341106,"roa":"-69.91%","roe":"-139.55%","lyrEps":-86.921415,"volumeRatio":3.983944,"shares":6384200,"dividePrice":0,"high":0.78,"amplitude":0.037641,"preClose":0.7598,"low":0.7514,"week52Low":0.5148,"pbRate":"1.13","week52High":34.65,"institutionHeld":0,"latestPrice":0.7548,"committee":0.373041,"eps":-39.1909,"divideRate":0,"volume":19898,"delay":0,"ttmEps":-39.1909,"open":0.78,"prevYearClose":0.6488,"prevWeekClose":0.7388,"prevMonthClose":0.7709,"prevQuarterClose":0.6488,"fiveDayClose":0.726,"twentyDayClose":0.713,"sixtyDayClose":0.7495},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DCOY\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DCOY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DCOY\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DCOY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DCOY","date":"2026-02-17","current":-0.019387,"percent":0.769231,"low":-1.594527,"twenty":-1.068716,"median":-0.994857,"eighty":-0.929367,"high":-0.790885,"avg":-1.018357,"sd":0.147981,"marketCap":4716629},"quantilePoints":[{"date":"2026-01-09","current":-0.982229,"twenty":-1.053663,"median":-1.026876,"eighty":-1.000088,"marketCap":4915816},{"date":"2026-01-16","current":-1.227403,"twenty":-1.203881,"median":-1.071522,"eighty":-1.040856,"marketCap":6142855},{"date":"2026-01-23","current":-0.957354,"twenty":-1.160688,"median":-1.045754,"eighty":-0.982229,"marketCap":4791324},{"date":"2026-01-30","current":-1.05749,"twenty":-1.109791,"median":-1.050666,"eighty":-0.994985,"marketCap":5292482},{"date":"2026-02-06","current":-0.790885,"twenty":-1.101882,"median":-1.039631,"eighty":-0.91832,"marketCap":3958189},{"date":"2026-02-13","current":-0.956844,"twenty":-1.071522,"median":-0.994921,"eighty":-0.926101,"marketCap":4788771},{"date":"2026-02-17","current":-0.942429,"twenty":-1.068716,"median":-0.994857,"eighty":-0.929367,"marketCap":4716629}],"updateTime":1771482302464},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DCOY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1146669991","title":"Decoy Therapeutics参与虚拟投资者会议“这意味着什么”环节,重点介绍近期宣布的全球准入承诺协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1146669991","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146669991?lang=zh_cn&edition=fundamental","pubTime":"2026-02-04 22:03","pubTimestamp":1770213795,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics Inc(简称:Decoy Therapeutics)近日参与了虚拟投资者会议“这意味着什么”环节,重点展示了公司最新宣布的全球准入承诺协议。该环节旨在深入解读这一重要协议对公司的战略意义及潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"gpt_icon":0},{"id":"2603682867","title":"BUZZ-盖茨基金会支持抗病毒药物的获取,诱饵治疗公司(Decoy Therapeutics)崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2603682867","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603682867?lang=zh_cn&edition=fundamental","pubTime":"2026-01-13 21:25","pubTimestamp":1768310709,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL4T3YE185:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"gpt_icon":0},{"id":"2601820407","title":"Salarius Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.94%报0.567美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601820407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601820407?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 23:33","pubTimestamp":1767713625,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日23时33分,Salarius Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.94%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.89%。其相关个股中,Lexaria Bioscience Corp C/Wts 14/01/2026 、Alumis Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大,Pmgc Holdings Inc.、Cyclerion Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为1801.27%、1449.09%、228.72%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Alumis Inc.,振幅分别为294.74%、161.40%、60.16%。Salarius Pharmaceuticals, Inc.公司简介:Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106233346a6faf9f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106233346a6faf9f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DCOY","BK4139","SLRX"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/DCOY\",params:#limit:6,delay:false,,,undefined,":[]}}